Aridis Pharmaceuticals, Inc. Gains 114.81%
Wed, May 31, 2023 at 07:47 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) jumped higher at $0.4, representing a gain of 114.8%. On Wed, May 31, 2023, ARDS:NASDAQ touched a New 2-Week High of $0.4. The stock appeared on our News Catalysts scanner on Wed, May 31, 2023 at 08:23 AM in the 'AGREEMENT' category. From Wed, May 17, 2023, the stock recorded 22.22% Up Days and 30.00% Green Days
The stock spiked on Wed, May 31, 2023 at $0.54 with a volume of 179M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- SunCar Technology Group Inc Ord (SDA:NASDAQ), 120.88%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 114.81%
- Marker Therapeutics, Inc. (MRKR:NASDAQ), 34.85%
- Inventiva S.A. (IVA:NASDAQ), 31.5%
- VIQ Solutions Inc. (VQS:NASDAQ), 28.76%
- Peak Bio Inc Com (PKBO:NASDAQ), 26.41%
- Bright Green Corporation (BGXX:NASDAQ), 24.01%
- Rockwell Medical, Inc. (RMTI:NASDAQ), 22.96%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 22.88%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 22.59%